Log In
Print this Print this

ViaDor-GLP1 agonist (formerly ViaDerm-GLP1 agonist)

  Manage Alerts
Collapse Summary General Information
Company Syneron Medical Ltd.
DescriptionGlucagon-like peptide-1 (GLP-1) agonist delivered using ViaDor transdermal delivery system
Molecular Target Glucagon-like peptide-1 receptor (GLP-1R) (GLP1R)
Mechanism of ActionGlucagon-like peptide-1 (GLP-1) receptor agonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today